Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Lamb Weston Holdings Inc

Start price
Target price
Perf. (%)
€78.10
02.08.22
-
02.08.23
19.59%
02.08.23

buy
Blucora Inc.

Start price
Target price
Perf. (%)
€19.30
02.08.22
-
02.08.23
19.17%
02.08.23

buy
Spie S.A.

Start price
Target price
Perf. (%)
€23.02
02.08.22
-
02.08.23
20.50%
02.08.23

buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€52.05
02.08.22
-
02.08.23
67.82%
02.08.23

buy
Dürr AG

Start price
Target price
Perf. (%)
€24.30
01.08.22
-
01.09.22
2.88%
04.08.22

buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€85.74
01.08.22
€90.00
01.08.23
10.43%
04.08.22

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€85.74
01.08.22
€90.00
01.08.23
10.43%
04.08.22

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€85.74
01.08.22
€90.00
01.08.23
10.43%
04.08.22

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€61.35
01.08.22
€65.00
01.08.23
10.43%
11.08.22

Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€61.35
01.08.22
€65.00
01.08.23
10.43%
11.08.22

Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€16.29
01.08.22
€64.00
01.08.23
21.62%
09.08.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Rising EBIT margin expected
buy
SAP SE

Start price
Target price
Perf. (%)
€91.80
01.08.22
-
01.08.23
-5.71%
14.09.22

Could be very worthwhile Investment >20% year
High dividend yield expected
EBIT decline > 20% expected
buy
SAP SE

Start price
Target price
Perf. (%)
€91.80
01.08.22
-
01.08.23
-5.71%
14.09.22

Could be very worthwhile Investment >20% year
High dividend yield expected
EBIT decline > 20% expected
buy
SAP SE

Start price
Target price
Perf. (%)
€91.80
01.08.22
-
01.08.23
-5.71%
14.09.22

Could be very worthwhile Investment >20% year
High dividend yield expected
EBIT decline > 20% expected
buy
Commerzbank AG

Start price
Target price
Perf. (%)
€6.76
01.08.22
-
01.08.23
3.40%
02.09.22

Nordex SE

Start price
Target price
Perf. (%)
€9.30
01.08.22
-
01.09.22
14.52%
16.08.22

Nordex SE

Start price
Target price
Perf. (%)
€9.30
01.08.22
-
01.09.22
14.52%
16.08.22

buy
Voestalpine AG

Start price
Target price
Perf. (%)
€22.32
01.08.22
€25.00
01.08.23
6.36%
04.11.22

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
ROE higher than 10% per year
Growths faster than the competition
Continental AG

Start price
Target price
Perf. (%)
€69.20
31.07.22
€50.00
31.07.23
-9.83%
23.01.23

Top 10 in its market
Known brand
Probably not worthwhile Investment
Very high cyclical dependencies
buy
Tui AG

Start price
Target price
Perf. (%)
€15.99
31.07.22
€25.00
31.07.23
-67.12%
01.08.23

EBIT growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
Very low/no dividend yield expected
buy
Suse S.A.

Start price
Target price
Perf. (%)
€18.29
31.07.22
€21.00
31.07.23
-12.63%
22.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Suse S.A.

Start price
Target price
Perf. (%)
€18.29
31.07.22
€21.00
31.07.23
-12.63%
22.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Sqli S.A.

Start price
Target price
Perf. (%)
€36.70
30.07.22
€38.00
30.07.23
32.97%
31.07.23

Could be worthwhile Investment >10% per year